Tofogliflozin hydrate etyltransferase Inhibitor II MERcK-5 reduces IFN-γ and IL-13
Pay in 4 interest-free payments of $30.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Live Spec
Tofogliflozin hydrate etyltransferase Inhibitor II MERcK-5 reduces IFN-γ and IL-13Tofogliflozin, also known as CSG 452, is a potent and high selective SGLT2 inhibitor under development the treatment of diabetes mellitus. Tofogliflozin improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus. Tofogliflozin dose dependently suppressed glucose entry into tubular cells. High glucose exposure (30 mM) for 4 and 24 h significantly increased oxidative stress generation in tubular cells, which were
Store: www.coronastickers.nu · Domain: www.coronastickers.nu
























